These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10458772)

  • 1. Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias.
    Charbonnier A; Gaugler B; Sainty D; Lafage-Pochitaloff M; Olive D
    Eur J Immunol; 1999 Aug; 29(8):2567-78. PubMed ID: 10458772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [In vitro stimulation of specific antileukemia T-cell response by dendritic cells derived from CD14+ acute monocytic leukemia cells].
    Sheng LX; Xie XB; Qiu GQ; Gu WY; Wang ZL; Wu HQ
    Ai Zheng; 2005 Nov; 24(11):1338-44. PubMed ID: 16552959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes.
    Kufner S; Fleischer RP; Kroell T; Schmid C; Zitzelsberger H; Salih H; de Valle F; Treder W; Schmetzer HM
    Cancer Immunol Immunother; 2005 Oct; 54(10):953-70. PubMed ID: 15789235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro immunization of patient T cells with autologous bone marrow antigen presenting cells pulsed with tumor lysates.
    Coulon V; Ravaud A; Gaston R; Delaunay M; Pariente JL; Verdier D; Scrivante V; Gualde N
    Int J Cancer; 2000 Dec; 88(5):783-90. PubMed ID: 11072249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrovirus-mediated IL-7 expression in leukemic dendritic cells generated from primary acute myelogenous leukemias enhances their functional properties.
    Bello-Fernández C; Stasakova J; Renner A; Carballido-Perrig N; Koening M; Waclavicek M; Madjic O; Oehler L; Haas O; Carballido JM; Buschle M; Knapp W
    Blood; 2003 Mar; 101(6):2184-90. PubMed ID: 12424204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.
    Spisek R; Chevallier P; Morineau N; Milpied N; Avet-Loiseau H; Harousseau JL; Meflah K; Gregoire M
    Cancer Res; 2002 May; 62(10):2861-8. PubMed ID: 12019165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of potent T(h)1 responses from patients with lymphoid malignancies after differentiation of B lymphocytes into dendritic-like cells.
    Mohty M; Isnardon D; Charbonnier A; Lafage-Pochitaloff M; Merlin M; Sainty D; Olive D; Gaugler B
    Int Immunol; 2002 Jul; 14(7):741-50. PubMed ID: 12096033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses.
    Choudhury BA; Liang JC; Thomas EK; Flores-Romo L; Xie QS; Agusala K; Sutaria S; Sinha I; Champlin RE; Claxton DF
    Blood; 1999 Feb; 93(3):780-6. PubMed ID: 9920826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro anti-leukemia activity of cord blood original cytotoxic T lymphocytes].
    Zeng LJ; Tan H
    Ai Zheng; 2005 Apr; 24(4):419-24. PubMed ID: 15820063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte-derived dendritic cells from HLA-matched allogeneic donors showed a greater ability to induce leukemic cell-specific T cells in comparison to leukemic cell-derived dendritic cells or monocyte-derived dendritic cells from AML patients.
    Lee JJ; Choi BH; Kang HK; Kim SK; Nam JH; Yang DH; Kim YK; Kim HJ; Chung IJ
    Leuk Res; 2008 Nov; 32(11):1653-60. PubMed ID: 18501426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficient generation of CD83 positive immunocompetent dendritic cells from CD14 positive acute myelomonocytic or monocytic leukemia cells in vitro.
    Hagihara M; Shimakura Y; Tsuchiya T; Ueda Y; Gansuvd B; Munkhbat B; Chargui J; Ando K; Kato S; Hotta T
    Leuk Res; 2001 Mar; 25(3):249-58. PubMed ID: 11226522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation on specific killing acute leukemia cell reaction of the cytotoxic T lymphocyte induced by dendritic cell pulsed with frozen-thawed antigen].
    He B; Qiu G; Xie X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):974-8. PubMed ID: 15646345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
    Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
    J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
    Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
    Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late dendritic cells are still able to evoke a potent alloreactive CTL response.
    Repnik U; Bergant M; Wraber B; Jeras M
    Immunobiology; 2008; 213(1):51-64. PubMed ID: 18207027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of autologous proliferative and cytotoxic T-cell responses by "leukemic dendritic cells" derived from blast cells in acute myeloid leukemia.
    Harrison BD; Adams JA; Briggs M; Brereton ML; Yin JA
    Blood; 2001 May; 97(9):2764-71. PubMed ID: 11313269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AML-loaded DC generate Th1-type cellular immune responses in vitro.
    Xing D; Decker WK; Li S; Robinson SN; Yang H; Segal H; O'Connor S; Yao X; Komanduri KV; McMannis JD; Jones RB; de Lima M; Champlin RE; Shpall EJ
    Cytotherapy; 2006; 8(2):95-104. PubMed ID: 16698683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B; Bodey B; Kaiser HE
    In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-transformed B-cells as efficient antigen presenting cells to propagate Aspergillus-specific cytotoxic T-lymphocytes.
    Ramadan G
    Egypt J Immunol; 2008; 15(1):145-57. PubMed ID: 20306679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.